ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Core Insights - ClearPoint Neuro, Inc. announced the appointment of Dr. Paul Larson as Chief Medical Officer starting January 2026 [1] - Dr. Larson has a significant history with ClearPoint Neuro, having served as an advisor focused on education and product development in cell and gene therapy delivery [1] Company Developments - The company is enhancing its leadership team with the addition of Dr. Larson, which may strengthen its capabilities in the medical device and therapy sectors [1] - Dr. Larson's expertise is expected to support ClearPoint Neuro's ongoing efforts in advancing cell and gene therapy technologies [1]